Ocugen gains rights to market Covid-19 vaccine in Mexico
Covaxin has obtained Emergency Use Authorization from the Mexican health authorities earlier for usage in adults.

Covaxin has obtained Emergency Use Authorization from the Mexican health authorities earlier for usage in adults.
Under the agreement, Moderna’s Covid-19 vaccine will be supplied to 18 countries in Latin America.
Mexico’s US border and strong manufacturing industry position it to take advantage of the growing US appetite for nearshoring.
ByThe vaccines produced in Mexico will be used as part of a national vaccination programme in the country.
Mexican health regulator COFEPRIS has authorised Russia’s Covid-19 vaccine, Sputnik V, for emergency use after the country entered into a…
Colombia's National Institute of Drug and Food Surveillance (INVIMA) has authorised emergency use of Pfizer and BioNTech’s Covid-19 vaccine.
The European Commission (EU) has approved a contract to purchase an initial 80 million doses of US biotech Moderna’s Covid-19…
Finnish drug delivery company DelSiTech has signed a licensing agreement with Mexico-based pharmaceutical group Innovare to develop a long-acting human…
ByThank you for subscribing to Pharmaceutical Technology